Zapata Computing Holdings Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, May 13, 2024 (GLOBE NEWSWIRE) — Zapata Computing Holdings Inc. (“Zapata AI” or the “Company”) (Nasdaq: ZPTA), the Industrial […]
Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024
Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024 Mont-Saint-Guibert, Belgium – May 13, 2024, 10:30pm CET […]
STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1×1 Investor Conference
HORSHAM, Pa., May 13, 2024 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical […]
FlexShopper, Inc. Reports 2024 First Quarter and Year End Financial Results
BOCA RATON, Fla., May 13, 2024 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq:FPAY) (“FlexShopper”), a leading national online lease-to-own (“LTO”) retailer […]
Stran & Company Postpones 2024 First Quarter Earnings Conference Call
Quincy, MA, May 13, 2024 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: SWAG) (NASDAQ: SWAGW), […]
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced […]
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
On track to submit NDA in the second half of 2024 for Tonmya™ for fibromyalgia; pre-NDA meeting with FDA scheduled for […]
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of […]
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
– Investigational New Drug application for non-small cell lung cancer trial with luvelta cleared by U.S. Food and Drug Administration; […]
Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
GAITHERSBURG, Md., May 13, 2024 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company), a clinical-stage biotechnology company pioneering mRNA […]
